Objective:To investigate the effect of hypertensive disorders in pregnancy (HDP) complicated with gestational diabetes mellitus (GDM) on neonatal birth weight, and to provide a basis for clinical risk assessment.Methods:This study was based on the China Birth Cohort Study (CBCS), which was established from November 2017 to December 2021 by Beijing Obstetrics and Gynecology Hospital, Capital Medical University. A total of 132 626 pregnant women from 14 medical institutions in 10 provincial regions were included after excluding women with multiple pregnancies, delivery before 28 weeks of gestation, and those with incomplete information on delivery outcomes. According to the presence or absence of HDP and (or) GDM, pregnant women were divided into control group (100 335 cases), HDP group (without GDM, 7 219 cases), GDM group (without HDP, 22 229 cases) and HDP+GDM group (2 843 cases). The general clinical data and pregnancy outcomes of each group were compared, and the risks of small for gestational age (SGA), large for gestational age (LGA), low birth weight (LBW) and macrosomia were analyzed. Logistic regression model was used to analyze the effects of HDP, GDM and HDP combined with GDM on neonatal birth weight.Results:(1) The prevalence of HDP combined with GDM was 2.14% (2 843/132 626), the prevalence of HDP was 7.59% (10 062/132 626), and the prevalence of GDM was 18.90% (25 072/132 626). The age, pre-pregnancy body mass index (BMI), the proportion of assisted reproductive technology conception and cesarean section rate in the HDP+GDM group were significantly higher than those in the other groups, and the median gestational age at delivery was significantly lower than that in the other groups (all
P<0.008 after adjustment). (2) After adjusting for confounding factors such as maternal age and pre-pregnancy BMI, the risk of SGA in HDP+GDM group was 3.56 times higher than that in the control group (95%
CI: 3.09-4.10,
P<0.001). After further adjustment for gestational age, the risks of LBW and macrosomia were 3.26 (95%
CI: 2.74-3.88,
P<0.001) and 1.33 (95%
CI: 1.13-1.56,
P=0.001) times higher in the HDP+GDM group than those in the control group. (3) Quantitative analysis of neonatal weight showed that in the overall cohort, compared with the control group, the birth weight of neonates in the HDP+GDM group and the HDP group were significantly lower regardless of confounding factors adjustment, while the birth weight of neonates in the GDM group increased before confounding factors adjustment and decreased after confounding factors adjustment (all
P<0.05). Compared with the overall cohort, the neonatal birth weight of the HDP group (
β values were -188.10 and -382.92 g, respectively) and the HDP+GDM group (
β values were -147.43 and -230.02 g, respectively) were further reduced in the preterm birth cohort.
Conclusions:HDP complicated with GDM not only increases the risk of LBW, but also increases the risk of macrosomia, but its effect on the birth weight of newborns, especially preterm infants, is more similar to the growth-inhibiting effect of HDP. HDP complicated with GDM is a complex high-risk pregnancy with high heterogeneity. In clinical practice, blood pressure control, placental function assessment, fetal growth dynamic monitoring and preterm birth risk management should be strengthened in addition to standardized blood glucose management to improve maternal and fetal outcomes.